Servatius Therapeutics

Movement for people. Biomaterials reducing spinal damage.

Servatius Therapeutics develops clinically-driven biomaterials to limit spinal cord function degradation.

Inspired by the balance of art and science, we aspire to heal with precision and humanity.

Scientific rigor.

Our research is grounded in systematic studies and clinical validation. We aim to combine a balance of empiricism, through experimentation and rationalism to link fundamental biology to clinical output.

Human focus.

Our principles of improving the human experience of those who may otherwise be crippled is core to our belief.

Inspired by tradition.

We believe we stand on the shoulders of giants, pushing forwards centuries of scientific rigour.

Servatius Therapeutics

Pioneers

About Us

Servatius Therapeutics bridges advanced clinical research and the wisdom of classical medicine to create next-generation treatments for reducing the damage from edema in spinal cord injuries. Inspired by the vision of Saint Servatius, we share his passion for helping the sick and injured, a compassion we hope to enable individuals to walk again after spinal cord injury. Our approach is rooted in precision, humanity, and diligence.

Founded by Dr Bea Duric and Ben Flowers, we are committed to translating scientific discoveries into real-world outcomes for patients. With the legacy of Saint Servatius as a guiding ideal, we work tenaciously to restore mobility and dignity.

Founders

© 2026 Servatius

All Rights Reserved

Connect with Servatius

Join our mission or request information.

Company

About

Science

Leadership

Resources

Publications

News

Careers

Connect

Contact